Enanta Pharmaceuticals Inc (STU:9EP)
€ 11.5 (0%) Market Cap: 337.82 Mil Enterprise Value: 243.65 Mil PE Ratio: 0 PB Ratio: 3.27 GF Score: 58/100

Enanta Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:00 PM GMT
Release Date Price: €11.7 (+5.41%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ENTA.OQ - Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Anu Pamrama. I am one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Rati Pinhey, Priyanka Grover, and Joyce Tso. Our next presenting company is Ananta, and presenting on behalf of the company, we have CEO Jay Lulu.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Anna Palm.

Before I begin, I want to remind you I'll be making some forward-looking statements. For a summary of the risks associated with these statements, please
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot